American Journal of Roentgenology, Vol 166, 1305-1310, Copyright © 1996 by American Roentgen Ray Society

ARTICLES

Timing of parenchymal enhancement on dual-phase dynamic helical CT of the liver: how long does the hepatic arterial phase predominate?

MG Frederick, BL McElaney, A Singer, KS Park, EK Paulson, SG McGee and RC Nelson
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.

OBJECTIVE: Dual-phase dynamic helical CT is now being used to detect and characterize benign and malignant hypervascular lesions in the liver. The purpose of this study is to define the timing and degree of parenchymal enhancement of normal liver during the hepatic arterial phase. SUBJECTS AND METHODS: This prospective study included 102 patients with known or suspected hypervascular hepatic lesions who underwent dual-phase helical CT. After unenhanced CT scanning, we injected iopamidol (Isovue 300; Bracco Diagnostics, Princeton, NJ) at 3 ml/sec for 120 ml, then at 2 ml/sec for 55-60 ml. Scan delay for the hepatic arterial phase was 25 sec and for the portal venous phase was 76 sec. Section thickness was 7 mm and pitch was 1:1. Operator-defined regions of interest were obtained from all three phases. RESULTS: Mean unenhanced attenuation of the liver was 51 +/- 12 H. The liver revealed progressive enhancement during the hepatic arterial phase as follows: an increase of 10 H occurred at a mean time of 33 +/- 4 sec, 20 H at 39 +/- 6 sec, 30 H at 44 +/- 8 sec, 40 H at 46 +/- 6 sec, and 50 H at 48 +/- 5 sec. At 20 H and 30 H of enhancement, we found a statistically significant difference (p < .01) for the mean times of men and women. Mean peak enhancement during the portal venous phase was 89 +/- 23 H. CONCLUSIONS: Because the hepatic arterial contribution to liver perfusion is approximately 30%, parenchymal enhancement greater than approximately 30% of peak might indicate portal venous predominance. In our study, this percentage corresponded to an increase of approximately 30 H. Therefore, detection of hypervascular lesions in the hepatic arterial phase may be compromised when imaging lasts longer than approximately 44 sec after the initiation of contrast material injection because 44 sec was the mean time for 30 H of enhancement in our series. However, variability between patients was marked, particularly between men and women. Furthermore, the data suggests that the hepatic arterial phase may be relatively brief and that it may be difficult to image properly using current helical CT technology.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M.-J. Kim, J. Y. Choi, J. S. Lim, J. Y. Kim, J. H. Kim, Y. T. Oh, E. H. Yoo, J. J. Chung, and K. W. Kim Optimal scan window for detection of hypervascular hepatocellular carcinomas during MDCT examination. Am. J. Roentgenol., July 1, 2006; 187(1): 198 - 206. [Abstract] [Full Text] [PDF]

				Y. Yagyu, K. Awai, M. Inoue, R. Watai, T. Sano, H. Hasegawa, and Y. Nishimura MDCT of Hypervascular Hepatocellular Carcinomas: A Prospective Study Using Contrast Materials with Different Iodine Concentrations Am. J. Roentgenol., May 1, 2005; 184(5): 1535 - 1540. [Abstract] [Full Text] [PDF]

				K. Awai, K. Hiraishi, and S. Hori Effect of Contrast Material Injection Duration and Rate on Aortic Peak Time and Peak Enhancement at Dynamic CT Involving Injection Protocol with Dose Tailored to Patient Weight Radiology, January 1, 2004; 230(1): 142 - 150. [Abstract] [Full Text] [PDF]

				H. K. Hussain, F. J. Londy, I. R. Francis, H. V. Nghiem, W. J. Weadock, A. Gebremariam, and T. L. Chenevert Hepatic Arterial Phase MR Imaging with Automated Bolus-Detection Three-dimensional Fast Gradient-Recalled-Echo Sequence: Comparison with Test-Bolus Method Radiology, February 1, 2003; 226(2): 558 - 566. [Abstract] [Full Text] [PDF]

				K. Awai, K. Takada, H. Onishi, and S. Hori Aortic and Hepatic Enhancement and Tumor-to-Liver Contrast: Analysis of the Effect of Different Concentrations of Contrast Material at Multi-Detector Row Helical CT Radiology, September 1, 2002; 224(3): 757 - 763. [Abstract] [Full Text] [PDF]

				V. S. Lee, M. T. Lavelle, N. M. Rofsky, G. Laub, D. M. Thomasson, G. A. Krinsky, and J. C. Weinreb Hepatic MR Imaging with a Dynamic Contrast-enhanced Isotropic Volumetric Interpolated Breath-hold Examination: Feasibility, Reproducibility, and Technical Quality Radiology, May 1, 2000; 215(2): 365 - 372. [Abstract] [Full Text]

				E. O'Riordan, C. M. Craven, D. Wilson, and P. J. Robinson Dual Phase Hepatic CT: Influence of Scanning Direction on Liver Attenuation Am. J. Roentgenol., May 1, 2000; 174(5): 1417 - 1421. [Abstract] [Full Text] [PDF]

				A. L. Spielmann, R. C. Nelson, C. R. Lowry, G. A. Johnson, G. Sundaramoothy, D. H. Sheafor, and E. K. Paulson Liver: Single Breath-hold Dynamic Subtraction CT with Multi-Detector Row Helical Technology—Feasibility Study Radiology, January 1, 2002; 222(1): 278 - 283. [Abstract] [Full Text] [PDF]